Trajan Group Holdings (ASX:TRJ) Common Stock : A$101.5 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings Common Stock?

Trajan Group Holdings's quarterly common stock increased from Dec. 2022 (A$101.2 Mil) to Jun. 2023 (A$101.3 Mil) and increased from Jun. 2023 (A$101.3 Mil) to Dec. 2023 (A$101.5 Mil).

Trajan Group Holdings's annual common stock increased from Jun. 2021 (A$48.2 Mil) to Jun. 2022 (A$96.3 Mil) and increased from Jun. 2022 (A$96.3 Mil) to Jun. 2023 (A$101.3 Mil).

Trajan Group Holdings Common Stock Historical Data

The historical data trend for Trajan Group Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings Common Stock Chart

Trajan Group Holdings Annual Data

Trend

Jun21

Jun22

Jun23

Common Stock

48.17

96.26

101.25

Trajan Group Holdings Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Common Stock	Get a 7-Day Free Trial			67.36	96.26	101.24	101.25	101.47

Trajan Group Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Trajan Group Holdings (ASX:TRJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (ASX:TRJ) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Argent Place, Ringwood, VIC, AUS, 3134

Website

https://www.trajanscimed.com

Trajan Group Holdings Ltd operates in the analytical science industry. The group operates in two segments namely, Analytical Products which design, manufacture, distribute, and sale of Analytical components and consumables, and Life Science Solutions which design, manufacture, distribute, and sale of pathology, automation workflow solutions, microsampling devices, testing, and data analysis. The majority of its revenue is derived from developing and manufacturing a range of precision consumable components and solutions. It operates predominantly in Malaysia, Japan, Australia, New Zealand, the USA, Europe, the Middle East, India and African countries.

Trajan Group Holdings (ASX:TRJ) Headlines

No Headlines